What is Supernus Pharmaceuticals's interest coverage?

Supernus Pharmaceuticals (SUPN) reported interest coverage of -14.9× in Q1 2024.

How has Supernus Pharmaceuticals's interest coverage changed year-over-year?

Supernus Pharmaceuticals's interest coverage decreased by 300.9% year-over-year, from 7.4× to -14.9×.

What does interest coverage mean?

Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.

Supernus Pharmaceuticals SUPN Interest coverage

Interest coverage at other companies

Zevra Therapeutics, Inc.ZVRA

-0×0.0×

Acadia PharmaceuticalsACAD

2.5×-5.9×

Neurocrine BiosciencesNBIX

101×+77.4×

XER

Xeris Biopharma Holdings, Inc.XERS

1.3×+0.9×

Jazz PharmaceuticalsJAZZ

-1.4×-3.2×

Collegium Pharmaceutical, Inc.COLL

2.4×+0.6×

Other financials

Income statement

See full

Revenue$207.7M+38.6%

Gross profit$184.3M+37.5%

Operating income-$8.3M+18.8%

Net income-$2.3M+80.6%

EPS (diluted)-$0.04+81.0%

Balance sheet

See full

Cash & equivalents$186.3M+60.8%

Total debt$40.9M+26.6%

Total equity$1.1B+4.5%

Total assets$1.5B+11.4%

Cash flow

See full

Operating cash flow$66.5M+117%

CapEx--100%

Free cash flow$66.5M+120%

Valuation

See full

Market cap$2.62B+43.7%

Enterprise value$2.47B+42.2%

P/S3.4×+0.6×

Profitability

See full

Gross margin89.4%+1.0pp

Operating margin-7.8%-18.9pp

Net margin-3.7%-13.0pp

FCF margin27.9%+3.4pp

Returns & leverage

See full

Return on equity-2.8%-9.1pp

Debt / equity0×0.0×

Current ratio2×-0.5×

Where this comes from

Calculated from Supernus Pharmaceuticals’s reported figures.

ebit/interest expense=-14.9×

Based on trailing twelve months.

The official record: Supernus Pharmaceuticals’s 10-Q, filed May 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Supernus Pharmaceuticals's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Supernus Pharmaceuticals's interest coverage?: Supernus Pharmaceuticals (SUPN) reported interest coverage of -14.9× in Q1 2024.
How has Supernus Pharmaceuticals's interest coverage changed year-over-year?: Supernus Pharmaceuticals's interest coverage decreased by 300.9% year-over-year, from 7.4× to -14.9×.
What does interest coverage mean?: Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.